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Abstract
The physiological role of RASSF9, a member of the Ras-association domain family (RASSF), is currently unclear. Here, we
report a mouse line in which an Epstein-Barr virus Latent Membrane Protein 1 (LMP1) transgene insertion has created a 7.2-
kb chromosomal deletion, which abolished RASSF9 gene expression. The RASSF9-null mice exhibited interesting phenotypes
that resembled human ageing, including growth retardation, short lifespan, less subcutaneous adipose layer and alopecia.
In the wild-type mice, RASSF9 is predominantly expressed in the epidermal keratinocytes of skin, as determined by
quantitative reverse-transcription PCR, immunofluorescence and in situ hybridization. In contrast, RASSF92/2 mice
presented a dramatic change in epithelial organization of skin with increased proliferation and aberrant differentiation as
detected by bromodeoxyuridine incorporation assays and immunofluorescence analyses. Furthermore, characteristic
functions of RASSF92/2 versus wild type (WT) mouse primary keratinocytes showed significant proliferation linked to a
reduction of p21Cip1 expression under growth or early differentiation conditions. Additionally, in RASSF92/2 keratinocytes
there was a drastic down-modulation of terminal differentiation markers, which could be rescued by infection with a
recombinant adenovirus, Adv/HA-RASSF9. Our results indicate a novel and significant role of RASSF9 in epidermal
homeostasis.
Citation: Lee C-M, Yang P, Chen L-C, Chen C-C, Wu S-C, et al. (2011) A Novel Role of RASSF9 in Maintaining Epidermal Homeostasis. PLoS ONE 6(3): e17867.
doi:10.1371/journal.pone.0017867
Editor: Frank Beier, University of Western Ontario, Canada
Received October 6, 2010; Accepted February 16, 2011; Published March 21, 2011
Copyright:  2011 Lee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the grant from the Ministry of Education, Taiwan (to Chang Gung University), and grants from Chang Gung University and
the Chang Gung Memorial Hospital (CMRPD 160053 and BMRP021 to YSC). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lcm5132@mail.cgu.edu.tw
Introduction
The RASSF proteins comprise an evolutionarily conserved
protein family of ten members (RASSF1 to RASSF10) in
vertebrates [1]. RASSF1 through RASSF6 all harbor C-
terminal Ras-association (RA) domains and are grouped
together as the C-terminal RASSF family, while RASSF7
through RASSF10 all contain N-terminal RA domains and are
grouped as the N-terminal RASSF family. The members of the
N-terminal RASSF family lack the characteristic Sav–RASSF–
Hpo (SARAH) domains found in members of the C-terminal
RASSF family [2]. The C-terminal RASSFs, as well as RASSF8
and RASSF10 of the N-terminal RASSFs, have been reported
to show reduced expression in various cancers, and are therefore
considered to be tumor suppressors [2,3,4,5]. RASSF9 was
originally named P-CIP1 (PAM C-terminal interactor 1)
following its identification as a peptidylglycine-amidating
monooxygenase (PAM)-trafficking protein, which has been
linked to the recycling of endosomes [6] and interaction with
N - ,K -a n dR - R a sp r o t e i n si nG S Tp u l l - d o w na s s a y s[ 7 ] .
Although the gene encoding RASSF9 is known to be expressed in
multiple organs, including testis, kidney, skeletal muscle, liver,
l u n g ,b r a i n ,a n dh e a r t[ 6 ] ,i t sb i ological and physiological roles
are not yet fully understood.
Recently, we obtained an Epstein-Barr virus Latent Membrane
Protein 1 (LMP1) transgene-insertion-derived mutant mouse line,
which was a RASSF9 deficient mutant with phenotype typical of
the alopecia syndrome. In normal skin, the proliferative cells are
confined to a single basal layer, and the non-proliferative
differentiating cells are located in the suprabasal layers. At the
final stage of differentiation, the stratum corneum is formed at the
outer layer of the epidermis, where it serves as a barrier that
prevents epidermal water loss [8]. The stratum corneum is
composed of a number of proteins, including loricrin, involucrin
and filaggrin, all of which are associated with keratin interme-
diate filaments [9]. Calcium-induced differentiation of primary
mouse keratinocytes in culture provides a well-established model
for the complex program of differentiation that occurs in vivo in
the transition from the basal to upper epidermal layers [10].
Since a particular group of epithelial cells among epidermal
epithelium is responsible for generating new hair follicle
epithelium during each hair cycle [11,12], the intriguing
phenotype of the mutant mice therefore prompted us to
investigate the possibility that RASSF9 plays some important
roles in regulating epidermal homeostasis.
Here, we show that RASSF9 is predominantly expressed in
epidermal keratinocytes of skin, and loss of RASSF9 expression
results in hyperplasia and aberrant differentiation of epidermis.
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17867The results of our in vitro study of mouse primary keratinocytes
showed that RASSF9 mediated growth suppression and
activation of the differentiation program. The mechanism by
which RASSF9 mediates keratinocyte growth suppression may
rely on the regulation of cell-cycle inhibitor p21Cip1, as
demonstrated by the results of reciprocal alterations between
deficient RASSF9 expression and its compensation in mouse
primary keratinocytes. Taken together, our findings show that




All animal experiments were approved by the Institutional
Animal Care and Use Committee (IACUC) at the Chang Gung
University, Taiwan (Permit Number: CGU10-027), and were
carried out in accordance with the relevant guidelines. The mice
were bred and maintained under a consistent temperature of 21–
23uC, a relative humidity of 50–70%, and a 12-hr light-dark cycle
with normal access to water and chow. In all experiments, mice
were sacrificed by ether inhalation.
Generation of transgenic mice
The utilized transgene was the nasopharyngeal carcinoma
(NPC)-derived LMP1 (NLMP1) gene, including the upstream
promoter, coding sequences, and the 59-untranslated region [13].
Transgenic mice were generated as follows. Briefly, the relevant
EcoRI-HindIII fragment was injected into fertilized oocytes from
ICR strain mice. Founders were crossed with ICR mice, and PCR
and Southern blot analysis were used to screen progeny for the
presence of the transgene.
Southern blotting
For Southern blotting, 20 mg of tail-tissue-derived genomic
DNA was digested with either EcoRIo rHindIII, which do not cut
the transgene. The digests were resolved by electrophoresis, and
the DNA was transferred to a nylon membrane (Hybond-N,
Amersham Biosciences, Piscataway, NJ). Probes were prepared
using the PCR DIG Probe Synthesis Kit (Roche Molecular
Biochemicals, Mannheim, Germany). The probes were designed
from the transgene sequence or the mutated genome, and were
designated Tg_probe or D_probe, respectively (Table S1).
Southern blotting was performed according the DIG system’s
protocol for filter hybridization (Roche Molecular Biochemicals,
Mannheim, Germany).
Inverse PCR amplification of the transgene-flanking
genomic sequences
Tail-derived genomic DNA was completely digested with TaqI
or BclI, and then self-circularized with T4 DNA ligase (2,5 mg/
mL). The ligation mixture was extracted with phenol:chloroform
(1:1,v/v) followed by chloroform alone, and DNA was precipitated
with ethanol and sodium acetate (pH 5.2). The self-ligated DNA
(1 mg) was used as the template for PCR amplification of the EcoRI
and HindIII flanking genome sequence of the insertion fragment.
The utilized primers were specific for both end sequences of the
transgenic DNA (Supplementary Information Table S1).
RNA isolation
RNA from tissues and keratinocytes was prepared by TRIzol
extraction according to manufacturer’s protocol (Invitrogen,
Karlsruhe, Germany).
RT-PCR and QRT-PCR
One mg of total RNA was subjected to reverse transcription
using an oligo-dT primer (Invitrogen, Carlsbad, CA). The reaction
mixture was then amplified using gene-specific intron-crossing
oligonucleotide primer pairs specific to the genes encoding mouse
RASSF9, p21Cip1 and the reference genes of b-Actin, 3-phosphate
dehydrogenase (GAPDH) and hypoxanthine phosphoribosyltrans-
ferase (HPRT1). Quantitative RT-PCR was performed on a
LightCycler (Roche Molecular Biochemicals, Mannheim, Ger-
many) according to manufacturer’s instructions, using the
FastStart DNA Master SYBR Green I mix (Roche Molecular
Biochemicals, Mannheim, Germany). The amplification condi-
tions were as follows: 95uC for 10 minutes followed by 45 cycles of
95uC for 10 seconds, 60uC for 10 seconds, and 72uC for 10
seconds. The cycle threshold (Ct) values were normalized with
respect to those of the reference genes. The oligonucleotide
sequences of the utilized primers are listed in Supplementary
Information Table S1.
BrdU-incorporation assays in vivo and in vitro
Mice were in vivo pulse-labeled with BrdU (250 mg/g body
weight; Sigma Chemical Corp., St Louis, MO) via intraperitoneal
(i.p.) injection, and skin tissues were harvested after two-hr
incubation. Each sample was fixed in formalin, embedded in
paraffin, and sectioned at 4 mm. The sections were deparaffinized,
rehydrated, subjected to antigen retrieval in citrate buffer, and
then subjected to immunohistochemical staining using specific
antibodies against BrdU (Serotec, Oxford, UK) and keratin 14
(Covance, Berkeley, CA) according to the protocol for the utilized
anti-bromodeoxyuridine-fluorescein kit (Roche Molecular Bio-
chemicals, Mannheim, Germany), with the DNA-denaturation
step modified to incubating the slides in 2 M HCl, for 20 min at
37uC. Chicken anti-rat IgG conjugated with FITC was used for
BrdU detection (Santa Cruz, CA), while goat anti-rabbit IgG
conjugated with TRITC was used for K14 detection (Jackson
ImmunoResearch Laboratories, West Grove, PA). Nuclei were
stained with 496-diamidin-2-phenylindol-dihydrochloride (DAPI;
Sigma Chemical Corp., St Louis, MO). The resulting images were
examined and photographed under a laser-scanning confocal
microscope (Leica TCS SP2; Leica, Germany or LSM 510 Meta
NLO; Carl Zeiss, Inc., USA).
For the in vitro assay, mouse primary keratinocytes were seeded
to 48-well plates and incubated with growth medium (0.06 mM
calcium) for 17 hr, followed by infection with or without a
RASSF9-encoding recombinant adenovirus for 24 hr. Subse-
quently, the cultures were plated with fresh medium containing
0.06 mM calcium and incubated for another 48 hr. Keratinocytes
were pulse-labeled with 10 mM BrdU for 2 hr and then harvested,
and BrdU incorporation was analyzed by ELISA according to the
manufacturer’s protocol (Cell Proliferation Biotrak ELISA System;
Amersham Biosciences, Piscataway, NJ). The BrdU immunoflu-
orescence staining was performed according to the protocol
described above.
Bacterial expression of RASSF9, and anti-RASSF9
antibody preparation
The 285-1625nt fragment of the mouse RASSF9 cDNA (NCBI
RefSeq NM_146240) was cloned into the EcoRI-XhoI sites of the
pGEX-4T-1 vector (Amersham Biosciences, Piscataway, NJ). The
resulting pGEX-4T-1-RASSF9 plasmids were transformed into
Escherichia coli BL21 competent cells and grown to the appropriate
cell density at 37uC with Ampicillin selection. Protein expression
was induced by addition of 1 mM isopropyl-1-thio-b-D-galacto-
RASSF9 Regulated Epidermal Homeostasis
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17867pyranoside (IPTG) for 4 hr at 37uC, and the resulting GST-
RASSF9 fusion protein with a GST tag in the N-terminus were
purified and used to generate antiserum in rabbits. Specificity of
anti-RASSF9 antibody is confirmed by Western immunoblotting
of exogenously expressed RASSF9 protein (Figure S1).
Histology and immunofluorescence
Dorsal skin of mouse was fixed in 10% neutral buffered
formalin, embedded in paraffin, and sectioned at 4 mm. The
sections were deparaffinized, rehydrated, and then subjected to
H&E staining or Masson’s trichrome staining. The resulting
images were examined and photographed under a microscope
(Axioplan II; Carl Zeiss Microimaging Inc., Germany). For
immunofluorescence analysis, OCT-embedding frozen skin was
cut into 4-mm sections, fixed in ice-cold acetone for 30 sec (for
RASSF9 immunofluorescence staining) or neutral buffered
formalin for 15 min, and subjected to double-indirect immuno-
staining according to the IHC World protocol (http://www.
ihcworld.com/protocols/general_IHC). Finally, the specimens
were mounted with Vectashield (Vector Labs, Burlingame, CA)
and photographed by laser-scanning confocal microscopy as
earlier described. The primary antibodies used in these experi-
ments were as follows: anti-keratin 1, keratin 5, keratin 6, keratin
10 and keratin 14 polyclonal antibodies (Covance, Berkeley, CA);
rabbit anti-RASSF9 (generation described in Materials and
Methods). The utilized secondary antibodies were FITC- or
TRITC-conjugated (Jackson ImmunoResearch Laboratories,
West Grove, PA). Nuclei were stained with DAPI.
Construction of the recombinant adenovirus
The full-length RASSF9 gene was obtained from the RNA of
normal ICR mouse brain using RT-PCR. The resulting 1.3-kb
fragment was cloned into pCMV-HA (Clontech, Palo Alto, CA)
and amplified using specific primers designed to generate an HA-
tagged RASSF9 fragment. The amplified fragment was subcloned
into the NotI-XhoI sites of pShuttle-CMV and inserted into the
adenoviral backbone plasmid, pAdEasy-1, for amplification in
bacteria. Recombinant adenoviruses containing the RASSF9 gene
were generated according to the protocol for the utilized
adenovirus-construction system (http://www.coloncancer.org/
adeasy/protocol.htm). A GFP-encoding recombinant adenovirus
was used as the control. Expression of RASSF9 in adenovirally
infected keratinocytes was confirmed by immunoblotting with
anti-HA antibody. Titration of recombinant adenovirus was
performed by a plaque forming unit (PFU) assay in 293 cells
following the manufacturer’s instructions (Cell Biolabs).
Cell culture and viral infection
The isolations and incubations of epidermal keratinocytes were
done according to a web-published protocol (http://openwetware.
org/wiki/Mouse_keratinocyte_cultures) with minor modifications.
Briefly, epidermis was isolated from the skin of neonatal mice by
incubation with Dispase II overnight at 4uC. Epidermal
keratinocytes were dissociated by incubation of the skin samples
in Trypsin-EDTA for 20 min at room temperature, and the cells
were harvested by passing each sample through a sterile nylon
100-mm cell strainer (BD Falcon, Bedford, MA). The epidermal
keratinocytes were then centrifuged, resuspended, plated onto
collagen pre-coated dishes, and cultured in Eagle’s minimal
essential medium (EMEM; Cambrex, East Rutherford, NJ)
supplemented with 4% Chelex-100 treated fetal bovine serum
(FBS) (Bio-Rad Laboratories, Hercules, CA), 0.4 mg/mL hydro-
cortisone, 5 mg/mL insulin, 10 ng/mL epidermal growth factor
(EGF), 10
210 M cholera toxin, 2610
29 M triiodothyronine (T3),
100 units/mL penicillin, 100 mg/mL streptomycin, 2 mM L-Glu,
and 0.06 mM CaCl2. After 17 hr, the culture medium was
refreshed, and the cells were exposed to the recombinant
adenovirus. The inoculating medium was removed 24 hr post
infection. After infection, the cells were incubated in fresh media
containing 0.06 mM or 2 mM calcium for the indicated time.
Recombinant adenoviruses were produced and routinely used at a
multiplicity of infection (MOI) of 10, unless otherwise specified.
Western blotting
Adherent primary cells were harvested and homogenized at 4uC
for 20 min in RIPA lysis buffer (25 mM TRIS, pH 7.5, 150 mM
NaCl, 1% NP40, 1% Na-deoxycholate, and 0.1% SDS) containing
1 mM phenylmethylsulfonyl fluoride (PMSF), 0.3 mM aprotinin,
130 mM bestatin, 1 mM EDTA, and 1 mM leupeptin (Sigma
Chemical Corp., St Louis, MO). Each lysate was cleared of cell
debris by centrifugation, and each sample’s total protein
concentration was determined using the Bradford protein assay
reagent (Bio-Rad, Hercules, CA). Equal amounts of protein were
resolved by electrophoresis on SDS-polyacrylamide gels (Bio-Rad,
Hercules, CA), and then transferred to a polyvinylidene difluoride
membrane (PVDF) (Millipore Corp., Bedford, MA). Immunoblot-
ting was performed as previously described [14] using the
following specific primary antibodies: anti-filaggrin, anti-loricrin,
anti-keratin 14 (Covance, Berkeley, CA); anti-HA (Sigma
Chemical Corp., St Louis, MO) and anti-p21Cip1 (F-5; Santa
Cruz, CA). The proteins of interest were reacted with a
horseradish peroxidase-conjugated secondary antibody, and then
detected with an enhanced chemiluminescence system (Amersham
Biosciences, Piscataway, NJ). K14, which is constitutively
expressed in keratinocytes irrespective of the cell-growth condi-
tions, was used as the loading control.
In situ hybridization
Fresh dorsal skin tissue was embedded in optimum cutting
temperature (OCT) compound (Tissue-Tek, Sakura Finetek,
Torrance, CA), and 4-mm cryosections were cut and subjected to
in situ hybridization according to the protocols of the Anderson lab
(California Institute of Technology, Pasadena, CA; http://wmc.
rodentia.com/docs/Big_In_Situ.html). Fragments corresponding
to nucleotides (nt) 285–817 and 1126–1625 of the mouse RASSF9
cDNA (NCBI RefSeq NM_146240) were separately cloned into
the EcoRI-XhoI sites of the pBluescript II KS (+) phagemid vector
(Stratagene, La Jolla, CA) for riboprobe synthesis. Digoxigenin-
UTP (DIG)-labeled antisense and sense riboprobes were prepared
by in vitro transcription with DIG-11-UTP and either T3 or T7
RNA polymerase, according to the manufacturer’s protocol (DIG
Application Manual for In Situ Hybridization, 3
rd edition; Roche
Molecular Biochemicals, Mannheim, Germany). The hybridiza-
tion signal was detected as a dark precipitate that formed following
exposure to an alkaline phosphatase-labeled anti-DIG antibody
and a substrate containing nitroblue tetrazolium (NBT) (Promega,
Madison, WI) and 5-bromo-4-chloro-3-indolylphosphate (BCIP)
(Promega, Madison, WI).
Affymetrix Analysis
Total RNA was extracted from mouse primary keratinocytes of
the neonatal WT (n=1) and RASSF92/2 mice (n=2) by TRIzol
extraction per manufacturer’s instructions(Invitrogen). Briefly, one
10-cm culture plate of confluent monolayer of primary keratino-
cytes per sample was lysed in 1 mL TRIzol reagent after
maintenance for two days in low-calcium keratinocyte serum-free
medium with supplements (Invitrogen, Carlsbad, CA). The cell
lysate was mixed with 0.2 mL of chloroform and centrifuged at
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from the resultant aqueous phase by isopropanol, washed in 70%
v/v ethanol, air-dried and then resuspended in RNAse-free water
for subsequent assays. The A260/A280 ratio of all RNA samples
was between 1.8 and 2.1, and sample quality was verified by
electrophoresis on 1% agarose gel for 18S and 28S ribosomal
RNAs. The resultant samples of total RNA were submitted to the
Microarray & Gene Expression Analysis Core Facility, VGH
National Yang-Ming University Genome Research Center,
Taipei, Taiwan, for subsequent processing and assay with
Affymetrix GeneChip Mouse Genome 430 2.0 Array (Affymetrix,
Fremont, CA). All the data is MIAME compliant, and the raw
datasets are deposited in MIAME-compliant NCBI-Gene Expres-
sion Omnibus (GEO) database (Accession Number: GSE24190).
The resulting dataset was analyzed using GeneSpring software
(Silicon Genetics, Agilent Technologies, Santa Clara, CA).
Image quantitation and statistical analysis
Quantitation of image data was achieved using the image-
analysis programs ImageJ. (version 1.41) and ImageQuant (version
5.1). Analysis for statistical significance was examined using t-tests.
P values ,0.05 were considered statistically significant.
Results
Characteristics of a transgene-insertion-mutation mouse
line
Out of 21 independent Epstein-Barr virus (EBV) latent
membrane protein 1 (LMP1) transgenic mice, one mouse line
exhibited intriguing phenotypes showing growth retardation,
alopecia and short lifespan in homozygotes (2/2; Figure 1A–
C), and signs of haploinsufficiency for heterozygotes (+/2) for the
alopecia (Figure 1A). Homozygous mice (2/2) were born with
normal Mendelian frequency but started to die off rapidly after
two weeks past birth. At six weeks past birth, approximately 10%
of homozygous mutants survived to wean (Figure 1C, left panel),
but no remaining homozygotes survived beyond one year after
weaning. Overall, homozygous exhibited severe growth retarda-
tion and short lifespan compared to heterozygous and the WT
mice (Figure 1A–C). The mRNA transcript of LMP-1 transgene in
this line was not efficiently expressed in the neonate skin at the
onset of the pathology (Figure S2A, top panel). Meanwhile, LMP-1
protein expression in the skin of the transgenic mice at two weeks
of age was not detectable by Western blotting with anti-LMP-1
antibody (Figure S2B). Thus, it is likely that the observed skin
Figure 1. Characterization of the transgenic mutant mouse line. (A) Macroscopic phenotypes of mice of various genotypes were shown at
one, two, and six weeks after birth. (B) Growth curve analysis. The growth curves of the different genotypes exhibited an effect of haploinsufficiency
on body weight. The body weight of the homozygous mutant was severely reduced as compared to that of the heterozygous and WT mice. (C) The
survival rate. The survival rate of transgenic mutant mice was lower than that of the WT mice. Statistical analyses were performed using the SPSS13.0
software. P,0.05. +/+, wild type; +/2, heterozygous mutant; 2/2, homozygous mutant.
doi:10.1371/journal.pone.0017867.g001
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of endogenous gene expression rather than the consequence of
transgenic LMP-1 expression. Taken together, the results strongly
suggest that the transgene insertion in this mutant line unexpect-
edly disrupted a gene whose expression was crucial for
development.
Chromosomal deletion and gene silencing of the RASSF9
gene in the homozygous mutant line
In order to elucidate the molecular mechanism of the
transgene insertion in the mutant mouse line, we determined
the chromosomal integration site of transgene by Southern blot
analysis using the transgene as the probe (Tg_probe; Supple-
mentary Information, Table S1). A single band was detected
upon restriction digestion of the genomic DNA by the enzymes
HindIII and EcoRI, suggesting that the transgene had integrated
at a single locus, as the transgene contained no restriction sites
targeted by the enzymes (Figure 2A, left panel). In order to
identify the chromosomal location of the transgene-insertion
site, we used an inverse PCR approach [15]. Two flanking
fragments (designated H3F and RIF; Figure 2B) containing
short unique DNA sequences that were not part of the transgene
were recovered. The flankingD N Af r a g m e n t s ,w h i c hw e r e
assigned to the mouse chromosome 10D1 region, were
separated by about 7.2 kb, indicating that integration of the
transgene resulted in the deletion of about 7.2 kb of the genome
a tt h ei n s e r t i o ns i t e( F i g u r e2 B ) .T oc o n f i r mt h e s er e s u l t s ,w e
used the same blot to perform Southern hybridization with a
probe located within the putative 7.2-kb deletion (D_probe;
Table S1); no signal was detected in homozygous mutant (2/2)
mice (Figure 2A, right panel). The deleted genomic sequence
was mapped to an intron sequence approximately 178 bp
downstream of the first exon of the gene encoding RASSF9
(Figure 2B). The mapping of the deletion/transgenic insertion to
murine RASSF9 gene (accession number: AK041688) was
confirmed with the genomic sequence from the latest assembly
of the UCSC Genome Browser [July 2007 assembly (NCBI37/
mm9); http://genome.ucsc.edu]. Thus, we concluded that the
transgenic mice harbored a 7.2-kb chromosomal deletion within
the 32.2-kb intron of the RASSF9 gene, in close proximity to its
first exon. In this study, we routinely performed genotype
screening by genomic PCR using primers targeting the LMP-1
transgene and the deleted sequence of the RASSF9i n t r o n
(Figure S2A, bottom two panels). Further analyses of tissue
samples from homozygotes (2/2)d e m o n s t r a t e dt h a tt h e
chromosomal deletion resulted in RASSF9 gene silencing in
Figure 2. Chromosomal disruption and RASSF9 gene silence in transgenic mutant line. (A) Southern blot analysis. Genomic DNA samples
from mice of various genotypes were separately digested with HindIII or EcoRI. The left panel showed that a single hybridization band was detected
when the transgene was used as the probe. The right panel confirmed a deletion of the identified region in the homozygous mice, as determined by
the lack of signal from a probe locating this region. (B) Physical map of the RASSF9 gene. The sequences flanking the inserted transgene in mutant
mice were identified by positional cloning. Symbols: white box, RIF; gray box, H3F; black line, intronic DNA; dashed line, the region deleted by the
insertional mutagenesis. (C) Total RNA extracted from the indicated tissues of mice of the WT and RASSF92/2 (2/2) genotypes (n=3 per genotype)
were analyzed by RT-PCR using RASSF9 and b-Actin gene-specific primers. b-Actin was used as the internal control for respective samples. The RT-PCR
product was analyzed by 2% agarose gel electrophoresis. Similar results were obtained from two independent experiments in panel A. +/+, wild type;
+/2, heterozygotes; 2/2; homozygotes.
doi:10.1371/journal.pone.0017867.g002
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(RT-PCR; Figure 2C; Figure S2A, the top second panel).
Perturbation of skin architecture in RASSF92/2 mice
Since homozygous mutant mice showed phenotypes typical of
the alopecia syndromes, we next sought to characterize its skin
pathology. Hematoxylin and eosin (H&E) staining of fixed skin
tissue sections revealed thickening of the epidermis and dermis of
RASSF92/2 skin by ,3-fold and 1.7-fold, respectively, versus
that of the WT mice at two weeks old (Figure 3A and B). The
histological features of dermal and epidermal thickening of
RASSF92/2 skin could also be observed with Masson’s trichrome
staining, which stained collagen blue for better contrast of
collagen-rich dermis with collagen-free epidermis (Figure S3).
On the other hand, the subcutaneous adipose tissue of the mutant
mouse was only 60% of that of the WT mouse (Figure 3A and B;
Figure S3). In the mouse, the hair cycle consists three stages:
anagen (hair growth), catagen (apoptosis-driven regression), and
telogen (resting maintenance). Strikingly, in contrast to anagenic
WT hair follicles, the majority of the mutant hair follicles were at
Figure 3. Histological abnormalities in RASSF92/2 skin. (A) H&E staining of skin sections from two-week-old mice. The dashed yellow lines
denote the epidermis-dermis and dermis-adipose borders. Similar results were obtained from three independent pairs of mice. The low and high
magnification images were shown in the left and right panels, respectively. Left panel, scale bar =200 mm; Right panel, scale bar =20 mm. Epi,
epidermis; Der, dermis; Adi, adipose; HF, hair follicle. (B, C) Quantitative analysis of the thickness and cellular layers of the epidermis, dermis and
adipose tissues of histological skin sections from ten individual regions of each genotyping mouse at two weeks after birth. Values were measured by
thickness and numbers of cellular layer in panel (B) and (C), respectively. Mean 6 SD (n=3, per genotype); * P,0.001, ** P,0.005, *** P,0.05. Panel
A–C: +/+, wild type; +/2, heterozygotes; 2/2, homozygotes.
doi:10.1371/journal.pone.0017867.g003
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shafts [Figure 3A and Figure S3, lower left panels; contrast with
upper left (WT) panels]. These observations strongly suggest that
RASSF9, the gene disrupted by the transgene insertion in this
mutant line, is crucial for epidermal development.
Aberrant proliferation in skin of RASSF92/2 mice
The skin of RASSF92/2 mouse exhibited a significant
epidermal thickening. We therefore investigated whether RAFF9
affected the epidermal proliferation by determining bromode-
oxyuridine (BrdU) incorporation in the skin of two-week-old
Figure 4. Aberrant proliferation in RASSF92/2 skin. (A) BrdU incorporation (green) and K14 (red) were co-stained by immunofluorescence in
the skin cross-sections of two-week-old RASSF92/2 (2/2; right panel) and WT mice (+/+; left panel). Areas marked by yellow dashed line are
enlarged in the adjacent column (‘‘Enlarge’’). Scale bar =100 mm. ORS, outer root sheath; HB, hair bulb. The abbreviations Epi, Derm, Adi were
defined as described in Figure 3A. (B) High-magnification images of BrdU incorporation in dermal tissues. Abnormal patterns of proliferating cells in
Epi, ORS and HB of 2/2 skin are consistent with those observed in (A). The dashed white lines denote the epidermis-dermis border. Similar results
were obtained from three independent pairs of mice. Scale bar =20 mm. (C) Skin proliferation was evaluated by quantitation of BrdU incorporation
using ImageJ software. Analyses were performed for the number of BrdU-positive nuclei in basal layer (top panel; per mm of epidermis); the number
of BrdU-positive nuclei in dermal hair follicles (middle panel; per mm
2 of dermis layer); and the percentage of HB with more than five BrdU-positive
nuclei (bottom panel). Data represent scoring of at least 20 hair bulbs from each mouse and three mice for each genotype. *, P,0.05; **, P,0.001.
doi:10.1371/journal.pone.0017867.g004
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DNA; it is useful as a label of proliferating cells. Indeed,
immunofluorescence staining for BrdU-incorporated cells in skin
tissues revealed marked changes of cellular proliferation patterns
in the basal layers and hair follicles of RASSF92/2 mice versus
WT. (Figure 4A and B). BrdU incorporation doubled in the
epidermal basal layer of the RASSF92/2 mice versus WT
control (Figure 4A and B; 4C, top panel). Additionally, BrdU-
positive cells were 4-fold more in the outer root sheath (ORS) of
the hair follicles located at the region of dermis layer in
RASSF92/2 mice (Figure 4A and B; 4C, middle panel).
However, the BrdU-labeling hair bulb index, defined by the
ratio of the number of hair bulb (HB) with more than five BrdU-
immunolabeled nuclei to total number of HB, was reduced to
,15% of the WT control (Figure 4A and B; 4C, bottom panel),
revealing a remarkable loss of anagenic follicles in RASSF92/2
Figure 5. K6 is abnormally expressed in epidermis of RASSF92/2 skin. (A) Frozen sections of skin from two-week-old mice were double-
immunofluorescence stained for K6 (red) and K14 (green), with the merged signals in yellow. DAPI (blue) was used to for nuclear staining. Scale bar
=100 mm. Similar results were obtained from three independent mice. +/+, wild type; 2/2, RASSF92/2. The other abbreviations of Epi, Derm, Adi
were defined as described in Figure 3A. Areas outlined in white borders were enlarged for detailed views (insets). (B) High-magnification images of K6
and K14 expression, prepared as described above. Scale bar =20 mm.
doi:10.1371/journal.pone.0017867.g005
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epidermal homeostasis and hair-cycle regulation caused by
disruption of the RASSF9 gene.
We also examined the expression of keratin 6 (K6), a marker of
hyperproliferative epidermis, whose expression is highly restricted
to a single cell layer in the hair follicle that surrounds the innermost
layer of the outer root sheath, but otherwise not typically expressed
in epidermis [16,17,18]. In RASSF92/2 mice, K6 was highly
expressed throughout the epidermal layers and entire root sheath
of hair follicles in abnormally thick layers of cells (Figure 5).
Keratin 14 (K14), a marker of epidermal proliferating compart-
ment, was confined to the basal cells in WT skin as expected,
whereas it was also detected in the suprabasal layer of RASSF92/
2 mice, also abnormally thick, together with K6 (Figure 5). The
striking co-expression of K6 and K14 in abnormally thickened
epidermal tissues suggests hyperproliferation in the epidermis of
two-week-old RASSF92/2 mice (Figure 5).
Aberrant differentiation in skin of RASSF92/2 mice
Epidermal homeostasis of the skin requires a coordinated
regulation of cell proliferation and differentiation. Thus we
investigated the status of epidermal differentiation in RASSF92/2
mice. We performed immunofluorescence staining for keratin 5/
keratin 14 and keratin 1/keratin 10 (K5/K14 and K1/K10),
markers for the basal and suprabasal layers of the cutaneous skin,
respectively [19]. In RASSF92/2 mice at 4 days post-partum (dpp),
K5 and K14 were detected not only in the basal layer but also the
suprabasal layers of epidermis, abnormal patterns that echoed the
epidermal hyperplasia observed of two-week-old RASSF92/2 mice
(K5: Figure 6; K14: Figure 7). Moreover, detection of K1/K10
expression revealed drastic thickening of suprabasal layers in
RASSF92/2 mice, in contrast to the WT control (K1: Figure 8;
K10: Figure 9). Furthermore, aberrant expression of K1 and K10
was observed in RASSF92/2 follicles, an anomaly strongly
suggesting possible epidermalization of the hair follicles in the skin
of RASSF92/2 mice (Figures 8–9; detailed images of hair follicles in
8Band 9B). Finally, immunostaining offilaggrin,a marker expressed
by cells of granular layer, revealed abnormal expression of filaggrin
in multiple layers of granular cells beneath the stratum corneum of
RASSF92/2 mice at two weeks of age, in contrast to the thin-layer
pattern typically maintained in the granular layer of WT skin
(Figure 10; detailed images in 10B). Taken together, these findings
showed that RASSF92/2 mice suffered from a severe defect in
epidermal homeostasis characterized by abnormal thickening of
epidermis, dysregulated cellular proliferation, and disruption of
keratinocyte maturation asrevealed bythe alteredpatternsofkeratin
and filaggrin expressions.
RASSF9 expression profiles in WT mouse
To further evaluate the significance of RASSF9 gene expression
for normal mouse development, we determined the expression
Figure 6. Aberrant differentiation in the skin of RASSF92/2 mice—K5 (red). (A) Frozen sections of dorsal skins of WT (+/+) and RASSF92/2
(2/2) mice were immunostained with red fluorescence for K5 in 4-dpp mice. Scale bar =100 mm. (B) Images at higher magnification. Scale bar
=40mm. Blue, DAPI staining of cell nuclei.
doi:10.1371/journal.pone.0017867.g006
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two weeks old. Our results indicated that the RASSF9 mRNA was
expressed in multiple organs, with high-level expression seen in the
skin, moderate-to-high expression in the heart, lung and kidney,
and relatively low expression in the thymus, brain, stomach, liver,
intestine and spleen (Figure 11A). Interestingly, RASSF9 mRNA
expression in heart and lung increased with growth from one to
two weeks old, implicating a role of this gene in regulation of post-
partum maturation of these organs in addition to epidermis
development. We then isolated epidermal and dermal fractions
from the skin of 4-dpp WT mice and examined the site-specific
expression of RASSF9 mRNA in skin. The RASSF9 mRNA was
between two- and six-fold higher in the epidermal fraction than
the dermal fraction, depending on the reference gene used
(Figure 11B, top panel). The demarcation of epidermis and dermis
layers was confirmed by specific detection of mRNA for E-
cadherin (CDH1) and fibronectin (fn1) in the former and latter
fractions, respectively (Figure 11B, middle and bottom panels).
We further visualized the expression patterns of RASSF9
protein in mouse skin tissues by double immunofluorescence
staining of frozen sections using RASSF9- and K1-specific
antibodies. Western immunoblot detection of exogenously ex-
pressed RASSF9 confirmed the specificity of anti-RASSF9
antiserum (Figure S1). The RASSF9-specific signal was detected
throughout the entire epidermis of wild type (WT, +/+) mice at 4-
dpp while colocalizing with K1 in the suprabasal layer (Figure 11C;
higher-magnification images in Figure 11D). Immunofluorescence
signals specific for RASSF9 were not detected in the RASSF92/2
skin section, again demonstrating the specificity of the anti-
RASSF9 antiserum [Figure 11D; compare +/+ (left panels) with
2/2 (right panels)]. Quantification of the RASSF9 immunoflu-
orescent intensity using ImageJ software revealed a more
prominent expression of RASSF9 in suprabasal layers, compared
to that in the basal and granular layers (Figure 11C). In situ
hybridization with an antisense probe against the RASSF9 mRNA
further confirmed strong and specific expression of RASSF9 that is
prominent in suprabasal layer of normal mouse epidermis (Figure
S4).
RASSF9 affects keratinocyte growth and differentiation in
vitro
Since RASSF9 is expressed in the proliferating basal and
differentiating suprabasal epidermal layers, it may have significant
involvement in keratinocyte proliferation and differentiation.
Therefore, we isolated primary keratinocytes from RASSF92/2
mice and measured their BrdU incorporation. A moderate (1.5-
fold) but statistically significant increase in BrdU incorporation
(p,0.05) was detected in RASSF92/2 keratinocytes versus WT
keratinocytes, in terms of both extent of BrdU incorporation
and the percentage of BrdU-positive cells (Figure 12A). Converse-
ly, re-expression of RASSF9 by infection with the Adv/HA-
Figure 7. Aberrant differentiation in the skin of RASSF92/2 mice—K14 (red). (A) Frozen sections of dorsal skins of WT (+/+) and RASSF92/2
(2/2) mice were immunostained with red fluorescence for K14 in 4-dpp mice. The dashed white lines denote the epidermis-dermis border. Similar
results were obtained from three independent pairs of mice. Scale bar =100 mm. (B) Images at higher magnification. Scale bar =40 mm. Blue, DAPI
staining of cell nuclei.
doi:10.1371/journal.pone.0017867.g007
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RASSF92/2 keratinocytes (P,0.05; Figure 12B). These results
show that RASSF9 is involved in suppressing or regulating
proliferation of epidermal keratinocytes. As described above,
RASSF9 expression was prominent in suprabasal layers of
epidermis, and RASSF9 null mice exhibited aberrant differentia-
tion. These observations prompted us to test whether RASSF9 was
actively involved in keratinocyte differentiation. A high concen-
tration of calcium (2 mM) was used to induce the differentiation of
primary mouse keratinocytes in culture [10], and two markers,
loricrin and filaggrin, were used for evaluation of terminal
differentiation. We found that both loricrin and filaggrin were
expressed at lower levels in RASSF92/2 versus WT keratinocytes,
regardless of calcium concentrations and incubation lengths tested
(4 days, Figure 12C; 2 days, Figure S5A). In cells cultured in
2 mM calcium for 4 days, the levels of filaggrin and loricrin in
RASSF92/2 keratinocytes were about two-third and one-third,
respectively, of those in WT keratinocytes (Figure 12C). These
results suggest that the terminal differentiation process of
RASSF92/2 keratinocytes is deficient.
Figure 8. Aberrant differentiation in the skin of RASSF92/2 mice—K1 (red). (A) Frozen sections of dorsal skins of WT (+/+) and RASSF92/2
(2/2) mice were immunostained with red fluorescence for K1 in 4-dpp mice. The dashed white lines denote the epidermis-dermis border. Similar
results were obtained from three independent pairs of mice. Scale bar =100 mm. Note the abnormal staining of K1 expression of hair follicular cells
(*) in dermis of RASSF92/2 skin. (B) Images at higher magnification, with follicular sites of abnormal K1 expression identified by asterisks (*) in both
length-wise sections (top panels) and cross sections (bottom panels) of hair follicles. Scale bar =40 mm. Blue, DAPI staining of cell nuclei.
doi:10.1371/journal.pone.0017867.g008
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differentiation in RASSF92/2 keratinocytes were due to the loss
of RASSF9, we rescued RASSF9 expression by transducing cells
with Adv/HA-RASSF9, and examined the differentiation of
transduced cells. Our results revealed that filaggrin and loricrin
were induced by approximately 8- and 2.5-fold in cells that re-
expressed RASSF9 versus those expressing GFP (control), when
the cells were cultured under the differentiation-inducing condi-
tions (2 mM calcium) for 3 or 4 days (Figure 12D). Notably,
expression induction of filaggrin and loricrin by ectopic RASSF9
expression in RASSF92/2 keratinocytes was also observed in
growing condition (0.06 mM calcium) for 2 days (Figure S5B),
suggesting that RASSF9 expression intrinsically primed cells for
initial differentiation independent of calcium levels. Taken
together, these findings suggest that RASSF9 is required for
proper initiation of keratinocytes differentiation.
Figure 9. Aberrant differentiation in the skin of RASSF92/2 mice—K10 (red). (A) Frozen sections of dorsal skins of WT (+/+) and RASSF92/2
(2/2) mice were immunostained with red fluorescence for K10 in 4-dpp mice. The dashed white lines denote the epidermis-dermis border. Similar
results were obtained from three independent pairs of mice. Scale bar =100 mm. Note the abnormal staining of K10 expression of hair follicular
epithelium (*) in dermis of RASSF92/2 skin. (B) Images at higher magnification, with follicular sites of abnormal K10 expression identified by asterisks
(*) in both length-wise sections (top panels) and cross sections (bottom panels) of hair follicles. Both K1 and K10 are markers of early-stage
keratinocyte differentiation, suggesting a delay in epidermal and follicular keratinocyte maturation. Scale bar =40 mm. Blue, DAPI staining of cell
nuclei.
doi:10.1371/journal.pone.0017867.g009
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To gain insight into the potential involvement of cell-cycle
regulation in the RASSF9-mediated growth of keratinocytes, we
compared the Affymetrix microarray analysis data of gene
expression patterns between RASSF92/2 and WT keratinocytes
cultured in the growth medium. P21Cip1 (CDKN1A)w a s
identified among several transcripts shown to be down-regulated
in RASSF92/2 cells. The protein is a potent inhibitor of cyclin-
dependent kinases and is known to be a key checkpoint protein
for the transition of keratinocyte growth/differentiation [20]. To
test whether the expression levels of p21Cip1 varied in
keratinocytes cultured under growth (0.06 mM calcium) or
differentiation-inducing (2 mM calcium) conditions, we examined
p21Cip1 expression by Western blot analysis. Although the
p21Cip1 level was significantly lower in RASSF92/2 keratino-
cytes compared to WT keratinocytes when cells were cultured in
the growth medium (0.06 mM calcium) for 2 or 4 days
(approximately 60% and 50% of WT, respectively; Figure 13A),
this difference gradually decreased when cells were cultured in
the differentiation-inducing medium (2 mM calcium) from day 2
to day 4 (from 75% to 0%; Figure 13A). After 4 days of culture in
the high-calcium medium, the cells further progressed toward the
terminal differentiation stage; this was accompanied by a
dramatic reduction of p21Cip1 protein levels in both
RASSF92/2 and WT keratinocytes (Figure 13A, right panel).
High calcium induces terminal differentiation of keratinocytes
that is coincident with a more dramatic reduction of p21Cip1
[21], which can be used as an indicator of progression of
keratinocytes toward terminal differentiation in this study. Thus,
these results suggest that RASSF9 affects p21Cip1 expression
primarily in keratinocytes that are at the stages of growth or early
differentiation. To further test whether RASSF9 can modulate
p21Cip1 expression in keratinocytes as they progress from growth
to differentiation, we maintained in low-calcium condition
RASSF92/2 keratinocytes transduced to express recombinant
RASSF9. RASSF9 expression significantly induced p21Cip1
expression by 2.3-fold on day 1, but the fold-change diminished
thereafter over time (Figure 13B). However, p21Cip1 induction
in RASSF9-re-expressing RASSF92/2 cells did not occur under
differentiation-inducing condition (Figure 13C). These results
further support the hypothesis that RASSF9 affects p21Cip1
expression primarily in growth-phase or early-differentiating
keratinocytes. Taken together, these findings strongly suggest
that the reduction of p21Cip1 in RASSF92/2 keratinocytes
potentially form the basis for the cellular hyperproliferation
observed in the epidermis of RASSF92/2 mice.
Figure 10. Aberrant differentiation in the skin of RASSF92/2 mice—filaggrin (green). (A) Frozen sections of dorsal skins of RASSF92/2 and
WT control mice were immunostained with green fluorescence for filaggrin and red fluorescence for K14 in two-week-old mice. Blue, DAPI staining of
cell nuclei. Scale bar =100 mm. (B) Images of higher magnification for filaggrin staining (green fluorescence) in skin sections. The dashed white lines
denote the epidermis-dermis border. Similar results were obtained from three independent pairs of mice. Scale bar =20 mm; GL, granular layer; KL,
keratinocyte layer. Note the increased thickness and patchiness in layer of prominent filaggrin staining, as well as abnormal distribution of filaggrin
staining in keratinocyte layer and hair follicle (*).
doi:10.1371/journal.pone.0017867.g010
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The N-terminal (NT) RASSF protein family is an evolutionarily
conserved group that has orthologs in the lower vertebrate, Xenopus,
and the invertebrate, Drosophila [1,4]; these genes are believed to
potentially function in development. We first found that RASSF9
was predominately expressed in the stratified epithelium, where its
function appeared to be linked to epidermal homeostasis. Indeed,
absence of RASSF9 expression resulted in atypical histological
architecture of the skin of RASSF92/2 mice, characterized by
changes in thickness of histological architecture and abnormal
development of hair follicles. In addition, aberrant distributions of
various keratin markers for different stages of keratinocyte
differentiation was observed in RASSF92/2 skin, indicating an
inability to maintaina regulated program of epidermisdevelopment.
The stratum corneum can provide a mechanical barrier to
protect the body from the environmental damage and dehydra-
tion; maintenance of epidermal development and homeostasis is
thus critical for its proper function. The various anomalies
observed in the skin of neonatal RASSF92/2 mice may therefore
culminate in defective skin barrier function. In fact, assessment of
skin permeability using the toluidine blue penetration assays
showed that approximately 17% of heterozygous pups and 40% of
homozygous pups exhibited moderately increased dye permeabil-
ity of skin with a punctuated distribution of blue spots in
RASSF92/2 mice versus WT control suggesting slightly compro-
mised skin barrier for the RASSF9-deficient mice (Figure S6). In
vitro study of the role of RASSF9 in epidermal keratinocyte
proliferation and differentiation found that RASSF92/2 kerati-
nocytes exhibited diminished or delayed response to differentiation
induction by high calcium concentration, with attendant prefer-
ence for hyperproliferation. Furthermore, adenovirus-mediated re-
expression of RASSF9 could overcome those defects of the
observed block in the terminal differentiation or hyperproliferation
of RASSF92/2 cells. Based on these findings, we conclude that
RASSF9 is critical for the regulation of skin epithelial proliferation
and differentiation. To our knowledge, this is the first direct
observation of the novel role of RASSF9 in maintaining
homeostasis of cellular proliferation and differentiation.
Although the RASSF9-knockout mice strain was generated by a
transgenic insertion of the open-reading frame of an exogenous
recombinant gene—EBV LMP-1—we believe that gene silencing
by an intron disruption is not implausible. Various intronic
regulatory elements have been found to be critical for regulation of
gene expression [22,23,24,25,26]. In addition, the 7.2-kb intron
sequence replaced by the transgenic insertion contains a 150-bps
long sequence of purine-rich guanine-adenosine (GA) repeats
possibly required for proper splicing of the primary transcript [27].
Indeed, we have consistently detected no presence of RASSF9
mRNA or protein expression in RASSF92/2 tissues. At the same
time, neither mRNA transcripts of the LMP-1 transgene or its
protein product was present at detectable level for the length of
time frame in which the experiments were performed. Moreover,
overexpression of LMP-1 alone by in vitro transduction of primary
keratinocytes at a level drastically greater than the observed level
in tissue samples resulted in no altered filaggrin expression levels
(Figure S7). Even as it is likely that abrogated RASSF9 expression
directly contributed to the observed phenotypes, the link between
RASSF9 and the observed phenotypes may well be conclusively
established by targeted knockout of the RASSF9 allele.
The RASSF92/2 mouse line showed rapid death at two weeks
old, and the histological analysis revealed a severe defect of
pulmonary alveoli occurrence, marked by deficient septation of
saccules that results in reduced number of alveolar sacs whose size
are however grossly enlarged, as well as significant thickening of
alveolar epithelium (Figure S8). Thus, RASSF9 was crucial for the
maturation of organogenesis. The defective lung development of
the RASSF92/2 mice is likely the major causality of their failure
to thrive and premature death. Unexpectedly, we also observed a
slight decrease in the survival rate of WT mice progeny of a
heterozygous mother (+/2) before weaning that may be attributed
to cachexia of the heterozygous mother versus healthy WT mother
mice (Figure 1C). Consistent with this phenomenon, we observed
normal pups born from the WT mother with a normal survival
rate (data not shown).
The terminal differentiation marker, filaggrin, which is normally
expressed in the epidermal granular layer of WT skin, was
detected in multiple layers in RASSF92/2 mice skin (Figure 10).
However, in vitro-cultured RASSF92/2 keratinocytes were found
to have significant defects or delays in terminal differentiation.
This discrepancy could be explained by RASSF92/2 cells having
an unusual proliferative capacity in vivo, which might cause
multiple granular layers in epidermis by cell accumulation with a
characteristic of delayed differentiation.
RASSF9 is expressed throughout the entire epidermis of WT
skin, which consists of the basal layer of growing keratinocytes and
the suprabasal layer of differentiating keratinocytes (Figure 11C
and D; Figure S4). This further supports our contention that
RASSF9 plays a critical role in epidermal homeostasis. We showed
that the re-expression of RASSF9 in RASSF92/2 keratinocytes
could induce p21Cip1 expression and reduce DNA synthesis.
Indeed, quantitative analysis of p21Cip1 (CDKN1A) mRNA
expression in mouse skin tissue by QRT-PCR revealed a general
decrease of p21Cip1 mRNA in the skin of RASSF92/2 mice
(Figure S9). Additionally, we also attempted to determine the
protein level of p21Cip1 in skin tissue by Western blot, but
p21Cip1 protein was not detectable in skin tissue by this method
because of less p21Cip1 protein and high nonspecific mask in
there. Previous studies have shown that p21Cip1 inhibits DNA
Figure 11. RASSF9 expression profiles in WT mouse. (A) Quantitive RT-PCR analysis of RASSF9 mRNA expression in various tissues of WT mice
at one and two weeks old. The results were normalized with regard to the mRNA expression of b-Actin (top panel), GAPDH (middle panel), or HPRT1
(bottom panel). Values represent the mean 6 SD (one-week-old mice, n=4; two-week-old mice, n=5). (B) Quantitive RT-PCR analysis of RASSF9 (top
panel), E-cadherin (CDH1) (middle panel), and fibronectin (fn1) (bottom panel) mRNA expression in the epidermis and dermis of the WT skin at 4-dpp
old. The results were normalized to individual reference gene of b-Actin, GAPDH,o rHPRT1 (the reference gene is specified at the bottom). The results
were normalized with regard to the mRNA expression of b-Actin, GAPDH,o rHPRT1. Values represent the mean 6 SD (n=4). *P,0.05, **P,0.001. (C)
Frozen sections of 4-dpp skins were double-stained for RASSF9 (Red) and K1 (Green), with merged signals in yellow. ‘‘NC’’, negative control, with no
incubation in anti-RASSF9 anti-serum; immunostaining procedures for NC were otherwise identical to ‘‘anti-RASSF9’’ panels. Blue, DAPI staining of cell
nuclei. Scale bar =100 mm. Area in white frame was enlarged to show the RASSF9 location in the WT skin (upper right panel). The relative intensity of
RASSF9 in various epidermal layers of WT skin at 4-dpp were normalized to basal-layer signals (lower right panel). Data represent analyses by ImageJ
of five individual images from each mouse (n=3) and are presented as Mean 6SD fold intensity relative to basal layer. *, P,0.05. B, basal layer; S,
suprabasal layer; G, granular layer. (D) Higher-magnification images of K1 (green) and RASSF9 (red) co-staining in frozen sections of dorsal skins ofW T
(+/+) and RASSF92/2 (2/2) mice. No RASSF9 signal was detected in RASSF92/2 epidermis. The dashed white lines denote the epidermis-dermis
border. Similar results were obtained from three independent pairs of mice. Scale bar =20 mm. Epi, epidermis; Der, dermis.
doi:10.1371/journal.pone.0017867.g011
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via two distinct functional domains [28,29]. Reduced p21Cip1
expression, observed in RASSF92/2 keratinocytes and skin, is
thus likely to contribute to their hyperproliferation. Consistent
with this hypothesis, we found that the endogenous levels of
RASSF9 mRNA were initially induced when keratinocytes were
exposed to a calcium concentration of 2 mM (differentiation-
inducing conditions) for 1 day, but were thereafter reduced as
differentiation progressed (Figure S10). Additional attempts to
determine endogenous RASSF9 protein expression in keratino-
Figure 12. RASSF9 affects keratinocyte proliferation and differentiation. (A, B) RASSF9-mediated proliferation measured by BrdU
incorporation using a Cell Proliferation Biotrak ELISA kit (Amersham) and BrdU immunofluorescence. The BrdU incorporation rate was normalized to
the amount of input protein or nuclei. Values are shown as fold changes versus the control group or percentage of nuclei presented in top panel and
bottom panel, respectively. (A) BrdU incoporation rate was performed in mouse primary keratinocytes after two-day incubation under growth
medium. Mean 6 SD (n=3). *, P,0.05. (B) BrdU incoporation rate was evaluated from RASSF92/2 keratinocytes expressing HA-RASSF9 versus GFP
control by adenoviral post transduction on 1 day and then subjected to growth medium for 2 days. Mean 6 SD (n=2). *, P,0.05. (C, D) The terminal
differentiation of keratinocytes was analyzed by immunoblotting with specific antibodies against filaggrin and loricrin. K14 was used as loading
control. Total cell extracts were prepared from mouse primary keratinocytes incubated for the indicated time under condition for growth (0.06 mM
calcium) or differentiation (2 mM calcium). The intensity of protein expression was determined as the density of the relevant band normalized to that
of the K14 loading control, as determined by ImageQuant 5.1. The resultant values were further normalized to baseline (lane 1 of same blotting) and
shown below the images. Similar results were obtained from three independent experiments. (C) Primary RASSF92/2 and WT mouse keratinocytes
incubated in the indicated medium for 4 days. (D) Primary RASSF92/2 keratinocytes transduced with Adv/HA-RASSF9 or a GFP-expressing control
virus and then subjected to differentiation induction for 3 and 4 days. Panel B and D: +/+, wild type; 2/2, RASSF92/2.
doi:10.1371/journal.pone.0017867.g012
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we were able to confirm differential RASSF9 expression in skin
tissues by other means of biochemistry and immunohistochemistry
as described above. These findings suggest that RASSF9 gene
induction is required for triggering keratinocyte growth arrest that
facilitates subsequent differentiation.
Although RASSF9 null expression resulted in diminished
filaggrin expression indicative of altered or delayed terminal
differentiation in mouse primary keratinocytes, the disruption of a
single allele (RASSF9+/2) was not sufficient to yield this
characteristic (Figure S11). Notably, however, heterozygous
(RASSF9+/2) mice showed signs of haploinsufficiency, with milder
versions of the syndromes seen among the RASSF92/2 homozy-
gotes (Figure 1A–C). Although overexpression of RASSFF9 by
adenoviral transduction in RASSF92/2 keratinocytes efficiently
rescued filaggrin expression at low multiplicity of infection
(MOI=5), increasing dosages of RASSF9 beyond 5 MOIs were
not able to further enhance the filaggrin expression in RASSF92/2
keratinocytes (Figure S12A). Additionally, overexpression of
RASSF9 by adenoviral transduction in WT (RASSF9+/+) mice
keratinocytes also did not result in induction of filaggrin expression
under high-calcium condition (Figure S12B). This saturating nature
of RASSF9-induced filaggrin expression in mouse primary
keratinocytes implies a limit on dependence of filaggrin induction
on RASSF9, the intrinsic expression level of which is both necessary
and sufficient for normal pattern of filaggrin expression. These
findings indicate a possibility that RASSF9 may play an important,
decisive role in facilitating the initiation of keratinocyte differenti-
ation, rather than reinforcing it.
While we observed altered proliferations and attendant
anomalies in keratinocyte differentiation of RASSF92/2 tissues
and cells in vitro and in vivo, the question remains on the precise
nature of the alteration. It remains possible that RASSF9
deficiency results in altered preference for proliferation without
damaging the machinery required for initiation and maintenance
of the keratinocyte differentiation program, and the observed
changes in selected differentiation markers such as filaggrin and
loricrin represent the effect of this altered preference. Regardless,
it is apparent that RASSF9 directly or indirectly enforces entry of
keratinocyte differentiation, and in its absence cells fail to respond
Figure 13. The effect of RASSF9 on p21Cip1 expression in keratinocytes. (A) RASSF92/2 and WT mouse keratinocytes were cultured in
growth (0.06 mM calcium) and differentiation-inducing (2 mM calcium) medium for 2 days (left panel) and 4 days (right panel) prior to lysis and
immunoblotting with the indicated antibody. K14-normalized intensity of p21Cip1 protein signal was determined by ImageJ software. The results
were further normalized to baseline control (lane 1 of same blotting) and shown on the top of blot images. Mean 6 SD (n=3). *, P,0.05; +/+, wild
type; 2/2, RASSF92/2. (B) Expression by transduction of HA-RASSF9 or GFP as negative control in RASSF92/2 cells under the growth condition
(0.06 mM calcium) was examined for indicated time points. Immunoblotting and data analysis were performed as described in (A). Fold intensities
relative to respective GFP controls are shown on the top of blot images. Mean 6 SD (n=2). *, P,0.05. (C) Re-expression of RASSF9 in RASSF92/2
cells under differentiation-inducing condition. Recombinant adenovirus infection, cell-lysate harvesting, immunoblotting and data analysis were
performed as described in (B), except cells were subsequently incubated in 2 mM calcium medium for 2, 3 and 4 days on post transduction. Mean 6
SD (n=3).
doi:10.1371/journal.pone.0017867.g013
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recognized as an inducer of keratinocyte differentiation
[30,31,32,33]. Indeed, in addition to p21Cip1, our preliminary
microarray analysis of the gene expression profile of RASSF92/2
keratinocytes hint at possible alteration of pathways known to be
involved in epidermis development and keratinocyte differentia-
tions. Further study would be necessary to delineate the exact
mechanism by which RASSF9 governs the pathways and factors,
including p21Cip1, that are required in concert for proper
initiation of keratinocyte differentiation.
Taken together, our main findings with regard to RASSF9 in
keratinocyte growth and differentiation can be summarized as
follows: 1) RASSF9 mRNA induction in WT keratinocytes was
seen at the early stage of differentiation. 2) Overexpression of
RASSF9 in RASSF92/2 keratinocytes can overcome the defects
of differentiation program. 3) Overexpression of RASSF9 in
RASSF92/2 keratinocytes inhibited hyperproliferation of the
cells, which that linked to p21Cip1 induction under early growth
conditions. The expression of p21Cip1 is known to be increased in
cell populations adjacent to proliferation compartments (i.e., cells
that are poised to differentiate). Furthermore, the protein is
believed to be an important, p53-independent regulator of
differentiation-associated growth arrest [20,34,35,36].
RASSF9 has been reported to associate with Ras proteins [7].
Ras proteins mediate multiple cellular functions, including cell
proliferation, differentiation, survival, and apoptosis [37]. Over-
expression of Ras in the suprabasal epidermis or skin equivalent
has been reported to disrupt normal stratification, induce cell
invasion and proliferation, and trigger the development of skin
tumors [38,39,40]. Additionally, Ras may be associated with the
morphology, spreading, growth, and differentiation of keratino-
cytes [41,42,43,44]. However, high calcium-induced keratinocyte
differentiation has been associated with down-regulation of Ras
activity during the early stage of differentiation [45]. As we have
observed that RASSF9 is transiently induced when 2 mM calcium
is used to induce differentiation among keratinocytes, it would be
interesting in the future to examine whether RASSF9 binds to
endogenous Ras protein targets in keratinocytes under high-
calcium treatment, leading to the attenuation of Ras activity
during early differentiation in these cells.
Based on our present findings, we propose a dynamic model of
RASSF9 equilibration in keratinocytes at different differentiation
stages (Figure 14). In this model, the profile of the endogenous
RASSF9 gene expression is similar to that of the p21Cip1 expression
with a dual pattern in primary keratinocyte differentiation, which
was up-regulated by raising calcium to trigger early differentiation,
but down-modulated in keratinocytes under terminal differentia-
tion. Furthermore, we suggest that RASSF9 induces p21Cip1
expression in keratinocytes, which are then transitioned from the
proliferative compartment to the growth-arrested early differenti-
ation layer, where p21Cip1 functions in early differentiation-related
growth arrest (Figure 14A). Conversely, the lack of RASSF9
Figure 14. Schematic model of RASSF9-mediated maintenance of epidermal homeostasis through p21Cip1 in keratinocyte growth
and differentiation. (A) In WT keratinocytes, RASSF9 expression is induced in cells progressing through early differentiation, but decreases
thereafter as cells approach terminal differentiation. RASSF9 induces p21Cip1 expression in keratinocytes during growth and early differentiation,
which may mediate in differentiation-related growth arrest. (B) A scheme illustrating that down-regulation of p21Cip1 expression, due to the loss of
RASSF9 signaling in post-mitotic cells adjacent to the proliferation compartment, leads to the escape of keratinocytes from cell-cycle withdrawal and
their subsequent proliferation.
doi:10.1371/journal.pone.0017867.g014
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not sufficiently up-regulated in keratinocytes progressing to early
differentiation,allowingthesekeratinocytestoescapefromcell-cycle
withdrawal and potentially accounting for the epidermal hyperpla-
sia observed in these mice (Figure 14B).
Supporting Information
Figure S1 Specificity of rabbit anti-RASSF9 antiserum.
RASSF92/2 primary keratinocytes were transduced with Adv/
GFP (GFP) or Adv/HA-RASSF9 (HA-RASSF9) at indicated MOI
and incubated in low (2, 0.06 mM) or high (+, 2 mM) calcium ion
(Ca
2+) concentration. Protein lysates of transduced cells were
subjected to SDS-PAGE and Western immunoblot using the
RASSF9-specific rabbit antiserum generated as described in
Materials and Methods at a dilution of 1:1000. The membrane
was reprobed for Keratin-14 (K14) as loading control. In both
calciumconditions a majorband near 60 kDa,the approximate size
of HA-RASSF9, was detected by anti-RASSF9 antiserum only for
cells transduced with Adv/HA-RASSF9. The molecular weights of
the protein size markers labeled to the right of the blot are, starting
at the top, 170, 130, 100, 70, 55, 40, 35, 25, 15 kDa.
(TIF)
Figure S2 LMP-1 and RASSF9 gene expressions in LMP-1
transgenicmice.(A) Skin tissue RNA samples of heterozygous and
homozygous transgenic mice of 1 day post-partum (dpp; n=5) and 4
dpp (n=3) were subjected to RT-PCR for amplification of LMP-1
and RASSF9 transcripts. Separately, mouse genotyping was done by
PCR of tail DNA using the specific primers for the detection of LMP-
1 transgene insertion and RASSF9i n t r o nd e l e t i o n .I nt h ec D N A
samples of both heterozygotes (1-dpp: Tg-1 and Tg-2; 4-dpp: Tg-6
and Tg-7) and homozygotes (1-dpp: Tg-3 – Tg-5; 4-dpp: Tg-8) no
LMP-1 transcript was detected. RASSF9 transcript and the deleted
intron sequence targeted by the transgene insertion had been lost in
the homozygote samples. For the cDNA samples, NIH-3T3 cells
overexpressing full-length LMP-1 and skin tissue of WT mice at 7
dpp were used as positive controls of LMP-1 and RASSF9
transcriptions, respectively. Tail genomic DNA extracts of genotyp-
ing-confirmed heterozygous mice were used as positive control of
presence of both LMP-1 transgene insertion (‘‘LMP-1’’) and
transgene-replaced intron deletion of RASSF9 (‘‘del’’). b-Actin was
used as internal control. (B) Protein expressions of LMP-1 in LMP-1
transgenic miceat two weeks oldwere examined by immunoblot with
anti-LMP-1 antibody. In both WT mice and the two transgenic
mouse lines, Tg1 and Tg2, no LMP-1 protein expression was
detected. Theasterisk(*) denotesthefounder mouse linesubsequently
used for the experiments reported in this study. 293T cells transfected
with LMP-1 expression plasmid constructs pT7(E) and D94 [46,47],
and B95-8, the EBV-infected marmoset B-lymphoblastoid cell line
[48], were used as positive controls of LMP-1 protein expression. The
blot was reprobed for b-Actin as protein loading controls.
(TIF)
Figure S3 Histological abnormalities in RASSF92/2
skin. Masson’s trichrome staining of skin sections from two-week-
old mice. The dashed yellow lines denote the epidermis-dermis
and dermis-adipose borders. Similar results were obtained from
three independent pairs of mice. The black dashed line-framed
areas are enlarged in the panels on the right. Scale bar =100 mm.
Epi, epidermis; Der, dermis; Adi, adipose.
(TIF)
Figure S4 In situ hybridization of RASSF9 mRNA in
the dorsal skin of mice. Skin cryosection of two-week-old
mice were fixed in paraformaldehyde for in situ hybridization
assay. Top right panel: a positive brown signal was developed
using an antisense probe against the mRNA for RASSF9 in WT
mice. Top left panel: a sense probe was used as a negative
control; no signal was detected in WT mice. Bottom panel: no
signal was detected in RASSF92/2 mice, irrespective using a
sense probe (left) or antisense probe (right), which further
confirmed the probe specificity in this system. Similar results
were obtained in two independent experiments. Arrow, positive
signal in WT epidermis. Scale bar =100 mm; +/+,w i l dt y p e ;
2/2, RASSF92/2.
(TIF)
Figure S5 RASSF9 mediates the terminal differentiation
of keratinocytes. (A) The terminal differentiation of RASSF92/2
(2/2) versus WT (+/+) mouse keratinocytes was analyzed by
immunoblotting with specific antibodies against filaggrin and
loricrin. K14 was used as the loading control for keratinocytes.
Total cell extracts were prepared from mouse primary keratinocytes
incubated for 2 days under growth (0.06 mM calcium) or
differentiation-inducing (2 mM calcium) conditions. The intensity
of protein expression was determined as the density of the relevant
band normalized with respect to that of the K14 loading control; the
analysis was performed using the ImageQuant 5.1 software, and the
results are shown below the panel. (B) Re-expression of RASSF9 in
primary RASSF92/2 keratinocytes. Primary RASSF92/2 kerati-
nocytes were infected with Adv/HA-RASSF9 or a GFP-expressing
control virus for 24 hr in low-calcium medium, and then switched to
fresh growth (0.06 mM calcium) or differentiation-inducing (2 mM
calcium) medium for 2 days. The expression levels of the terminal
differentiation markers were detected as described in (A). Similar
results were obtained in three independent experiments. +/+, wild
type; 2/2, RASSF92/2.
(TIF)
Figure S6 RASSF92/2 mice with a moderate impair-
ment of skin barrier. Skin permeability assays on RASSF92/2
and control newborn pups were performed by toluidine blue dye-
penetration assays. RASSF92/2 pups showed moderate impaired
skin barrier in RASSF9 deficient pups (2/2), which exhibited
slight increase in dye penetration with a punctuated distribution as
compared with that of the WT control (+/+). Bottom panel was
the enlarged image of RASSF92/2 mice marked by * shown in
the top panel. Red arrows, signals of dye-penetration; +/+, wild
type; +/2, RASSF9+/2; 2/2; RASSF9 2/2.
(TIF)
Figure S7 Overexpression of LMP-1 could not reduce
the filaggrin expression. (A) Normal mouse primary kerati-
nocytes were infected with adenoviral vectors encoding LMP-1 or
GFP at MOI’s=5 or 10 in low-calcium concentration (0.06 mM)
for one-day infection, followed by incubation for 4-day in high-
calcium medium (2 mM) as previously described prior to lysis and
Western immunoblotting. (B) Intensity measurements of the
filaggrin bands. Data represent two separate blots. No statistical
differences in band intensities were detected.
(TIF)
Figure S8 Histological abnormalities in developing
RASSF92/2 lung. H&E staining of lung sections of mice at
two weeks old. The RASSF92/2 lung (2/2) exhibits stunted
progress of saccule septation versus WT lung (+/+), with grossly
enlarged alveoli. In the panels of RASSF92/2 section noticeable
thickening of pulmonary alveolar epithelium can be observed
(asterisks, *). (A) Low-magnification views of pulmonary alveoli.
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nary alveoli. Scale bar =40 mm.
(TIF)
Figure S9 Decrease of p21Cip1 (CDKN1A) mRNA in
RASSF92/2 skin. Total RNA of mice skins were extracted by
TRIzol reagent, and used to determine the mRNA level of
p21Cip1 in mouse skin tissue by QRT-PCR using p21Cip1 gene-
specific primers followed by normalization with regard to the
mRNA expression of the reference gene: (A) b-Actin, (B) GAPDH
and (C) HPRT1. Mean 6 SD (n=3, per genotypes); *, P,0.05; +/
+, wild type; 2/2, RASSF92/2.
(TIF)
Figure S10 Expression profile of RASSF9 mRNA in
normal mouse primary keratinocytes. Total RNA was
prepared from mouse primary keratinocytes cultured for the
indicated times in growth medium (0.06 mM calcium) or
differentiation-inducing medium (2 mM calcium). RASSF9 mRNA
expression was determined by QRT-PCR analysis using RASSF9
gene-specific primers followed by normalization with regard to the
mRNA expression of the reference gene: (A) b-Actin, (B) GAPDH
and (C) HPRT1. The results shown are given as the fold-change
(Mean 6 SD, n=3); * P,0.05; ** P,0.005.
(TIF)
Figure S11 RASSF9+/2 keratinocytes could be induced
to differentiate in a manner similar to that of WT
keratinocytes. keratinocytes from RASSF9-deficient heterozy-
gotes or WT mice were cultured under growth (0.06 mM calcium)
or differentiation-inducing (2 mM calcium) conditions for 4 days,
and the expression levels of filaggrin (a marker for terminal
differentiation) and K14 (loading control) were analyzed by
Western blotting. Similar results were obtained in three indepen-
dent experiments. +/+, wild type; +/2, RASSF9+/2.
(TIF)
Figure S12 RASSF9 expression could overcome the
differentiation defects in RASSF92/2 keratinocytes,
but increasing RASSF9 expression did not enhance
terminal differentiation in keratinocytes. (A) RASSF92/2
mouse primary keratinocytes were transduced by adenoviral
vectors encoding HA-tagged RASSF9 or the GFP control with a
viral dose of 5, 10 and 20 MOI for 1-day infection, and incubated
in differentiation-inducing medium (2 mM calcium) for 4 days.
Western blotting was used to examine the expression levels of
filaggrin (a terminal differentiation marker) and HA-RASSF9.
Similar results were obtained in two independent experiments. (B)
Normal mouse primary keratinocytes were infected with adeno-
viral vectors encoding HA-tagged RASSF9 or the GFP control
with a viral dose of 5, 10, 15 and 20 MOI for 1-day infection, then
incubated as described in (A) before lysis and Western blot
analysis. +/+, wild type; 2/2, RASSF92/2.
(TIF)
Table S1 Oligonucleotide primers used to amplify the
fragments for Southern probes, transgene-flanking
genome and gene identification.
(DOC)
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